Signal Detection
Signal Detection is a pharmacovigilance process that systematically identifies potential safety signals—i.e., new risks or changes in known risks associated with medicinal products—through structured analysis of adverse event and related data to determine whether further evaluation and regulatory action are warranted.
1.8K
Publications
113.5K
Citations
6.1K
Authors
2K
Institutions
Publications per year
2017–2026
496
1.8K
1–5 of 1.8K
6.1K
16
h-index
13
h-index
11
h-index
11
h-index
11
h-index
1–5 of 6.1K
2K
Inserm
Paris, France
24 h-index
138 publications
7.7K citations
Harvard University
Cambridge, United States
24 h-index
90 publications
7.4K citations
Uppsala Monitoring Centre
Uppsala, Sweden
23 h-index
101 publications
9.1K citations
Stanford University
Stanford, United States
21 h-index
64 publications
16.5K citations
Erasmus MC
Rotterdam, The Netherlands
19 h-index
96 publications
5.5K citations
Bordeaux Population Health
Bordeaux, France
18 h-index
56 publications
3.7K citations
Pfizer (United States)
New York, United States
17 h-index
38 publications
1.5K citations
United States Food and Drug Administration
Silver Spring, United States
17 h-index
49 publications
3.7K citations
1–8 of 2K
67 publications · 4.5K citations
35
h-index
56 publications · 5.7K citations
31
h-index
29 publications · 1.2K citations
21
h-index
19 publications · 1.3K citations
18
h-index
22 publications · 798 citations
18
h-index
1–5